Journal Publications

Our team of experts, The Breast Cancer Therapy Group, meets periodically to discuss important developments in breast cancer management and explore innovative ways to advance clinical practices.

Breast Cancer Therapy Expert Group

The BCTEG is a group of expert physicians and clinical researchers who have dedicated their careers to the treatment of patients with breast cancer.  The purpose of the group is to meet periodically to discuss important developments related to breast cancer management, with a particular emphasis on new findings and/or areas where guidance from established bodies, such as the National Comprehensive Cancer Network (NCCN) and the American Society for Clinical Oncology (ASCO) may be unresolved, or less well established.   The goal is to elicit the group’s opinions on a given topic as it relates to their own clinical practices, and more importantly, how this might impact busy oncologists in the community setting, where breast cancer is only one of many tumor types encountered.

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)

Click here to view the publication.

Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)

Click here to view the publication.

Breast Cancer Therapy Expert Group (BCTEG): A Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early Stage Breast Cancer

Click here to view the publication.

A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer

Click here to view the publication.

Gastrointestinal Cancer Therapy Expert Group

The GICTEG is a group of expert physicians and clinical researchers who have dedicated their careers to the treatment of patients with gastrointestinal cancer.  The purpose of the group is to meet periodically to discuss important developments related to gastrointestinal cancer management, with a particular emphasis on new findings and/or areas where guidance from established bodies, such as the National Comprehensive Cancer Network (NCCN) and the American Society for Clinical Oncology (ASCO) may be unresolved, or less well established.  The goal is to elicit the group’s opinions on a given topic as it relates to their own clinical practices, and more importantly, how this might impact busy oncologists in the community setting, where gastrointestinal cancer is only one of many tumor types encountered.

Connect with Us:

Total Health Conferencing

20423 State Road 7 F6-496, Boca Raton, FL 33498

Phone: 561-237-2845

Email: info@totalhealthconferencing.com